Showing 590 results
Archival description![[Ai] WHO Global Tuberculosis Report 2015.pdf](/uploads/r/null/f/e/8/fe850840f2401ca243299a921e22ec794889d7238881bfffddb4f2336d592871/efdb6f3e-2779-42ee-b0f5-1b339dd0bc65-_Ai__WHO_Global_Tuberculosis_Report_2015_142.jpg)
[Ai] WHO Global Tuberculosis Report 2015.pdf
![[Aii]WHO Global Tuberculosis Report 2016.pdf](/uploads/r/null/2/a/d/2adb1694723ae435ae9f63812be208018f6e91745c130c671dc4a498ec15077e/dbe2bbad-a164-4d3f-9277-d917e0990ece-_Aii_WHO_Global_Tuberculosis_Report_2016_142.jpg)
[Aii]WHO Global Tuberculosis Report 2016.pdf
![[Aiii]WHO Global Tuberculosis Report 2017.pdf](/uploads/r/null/c/b/5/cb56386e1abc91efb40db157e5773e3b591d393d346c8315f9f83fff062e5425/b4ea1f4b-5297-47ba-bf4a-d896d5d6d0b9-_Aiii_WHO_Global_Tuberculosis_Report_2017_142.jpg)
[Aiii]WHO Global Tuberculosis Report 2017.pdf
![[Av]WHO Global Tuberculosis Report 2019.pdf](/uploads/r/null/4/7/f/47f7b6e3d106704d13073e8d4fd7627ad7b3fbfe58935c53c03d645938e941e1/9c95df90-a7e6-4c80-986e-1f79f2f726dc-_Av_WHO_Global_Tuberculosis_Report_2019_142.jpg)
[Av]WHO Global Tuberculosis Report 2019.pdf
![[C] FIKIA Project in Kenya.pdf](/uploads/r/null/a/e/f/aef52154c9719dc3cdfcf9218b08f0270ca15257e6f173865fb49eacb7e517dc/44c1a770-8198-4d5b-b729-64a6fd021be5-_C__FIKIA_Project_in_Kenya_142.jpg)
[C] FIKIA Project in Kenya.pdf
![[Aiv]WHO Global Tuberculosis Report 2018.pdf](/uploads/r/null/9/d/0/9d0e0eb62785075c49cf0366af81810aa2b6fa2fd034abbceab790a78365fde2/9048910d-9f55-46a8-88f8-d682427060a4-_Aiv_WHO_Global_Tuberculosis_Report_2018_142.jpg)
[Aiv]WHO Global Tuberculosis Report 2018.pdf
![[A] Patent US8838216.pdf](/uploads/r/null/8/5/9/859fbf78c9d4c6d4eddcdfb710208ff169271cbbe8581c0db288ee8c031f5a23/b46f4e9a-07ab-4f93-8584-f6057b5bb983-_A__Patent_US8838216_142.jpg)
[A] Patent US8838216.pdf
![[B] CARTO® CONFIDENSE™ Module with Ripple Mapping.pdf](/uploads/r/null/2/3/2/23281df8fa81b420620187409150b683bb945cefb22a56ccad20692541c8ef80/dd5b7edf-5cb6-48fd-8c9d-51f51f933450-_B__CARTO_r__CONFIDENSE_tm__Module_with_Ripple_Mapping_142.jpg)
[B] CARTO® CONFIDENSE™ Module with Ripple Mapping.pdf
![[G] Case Study Ripple Mapping Dr. Atwater - YouTube.pdf](/uploads/r/null/9/8/4/9844ccf044e1d3b36ffcdfce4865363310d4de64b76d3fc39b94f87a315f35b5/4fd4b237-6192-42e7-971f-b7123f795fe7-_G__Case_Study_Ripple_Mapping_Dr._Atwater_-_YouTube_142.jpg)
[G] Case Study Ripple Mapping Dr. Atwater - YouTube.pdf
![[D] On-demand training videos from the Johnson & Johnson education platform.pdf](/uploads/r/null/e/d/e/ede89d39ed868086a6a1af79ba4fb636cbfdf209ff4a418fcb406ec963421d3b/3d60d9d9-379f-404e-ad6d-6418eac9812f-_D__On-demand_training_videos_from_the_Johnson___Johnson_education_platform_142.jpg)
[D] On-demand training videos from the Johnson & Johnson education platform.pdf
![[C] The Value of Ripple Mapping .pdf](/uploads/r/null/0/1/a/01adc88139c7f4c46014587fb9d1fe1fbc9dbc38cdcdd2f100fd779b9dcb50b8/0dffd0bc-5d4f-466d-83c4-f0f337273d41-_C__The_Value_of_Ripple_Mapping__142.jpg)
[C] The Value of Ripple Mapping .pdf
![[B] Endobronchial valve insertion to reduce lung volume in emphysema. Interventional procedures guidance [IPG600].pdf](/uploads/r/null/4/f/9/4f96a8289da6f409bd8bf7ed529fe34629561e478478a522224d23fca6f592df/343d76db-5d94-405f-b1b5-0a0dc914b4ba-_B__Endobronchial_valve_insertion_to_reduce_lung_volume_in_emphysema._Interventional_procedures_guidance__IPG600__142.jpg)
[B] Endobronchial valve insertion to reduce lung volume in emphysema. Interventional procedures guidance [IPG600].pdf
![[E] NHS England Specialist Commissioning guidance Lung volume reduction by surgery or endobronchial valve for severe emphysema in adults.pdf](/uploads/r/null/6/5/0/65076b7c0849f0c0189a18b39d622f8c5f226e0f2174c0a89619ea0ce428ae39/9fa6c55e-43be-4475-81f1-545d6d18480f-_E__NHS_England_Specialist_Commissioning_guidance_Lung_volume_reduction_by_surgery_or_endobronchial_valve_for_severe_emphysema_in_adults_142.jpg)
[E] NHS England Specialist Commissioning guidance Lung volume reduction by surgery or endobronchial valve for severe emphysema in adults.pdf
![[G] Pulmonx Zephyr valve.pdf](/uploads/r/null/f/9/0/f90bfe237acefc35119e7609151b96cd00628a943df50b358a252276e3eb074c/6053c1ce-af83-4ae2-b9c9-a1a7b23693f0-_G__Pulmonx_Zephyr_valve_142.jpg)
[G] Pulmonx Zephyr valve.pdf
![[H] UK Taskforce for Lung Health A National Five Year Plan for Lung Health (Recommendation 3B P57) 2019.pdf](/uploads/r/null/1/f/a/1fa4627b8103efd7ac7be53be778c82de2186adf3e28cb89c3dffa3a2161c30c/c14158fe-b62c-4619-b6e5-31e31735685d-_H__UK_Taskforce_for_Lung_Health_A_National_Five_Year_Plan_for_Lung_Health__Recommendation_3B_P57__2019_142.jpg)
[H] UK Taskforce for Lung Health A National Five Year Plan for Lung Health (Recommendation 3B P57) 2019.pdf
![[C] Chronic obstructive pulmonary disease in over 16s diagnosis and management. NICE guideline [NG115].pdf](/uploads/r/null/7/b/7/7b75f93c2a5f75f8a851009965aa91f5a27c77a0a79e6c2139ee6e1b8ea8351e/639c985e-1ebe-4764-8c19-379de90d0e40-_C__Chronic_obstructive_pulmonary_disease_in_over_16s_diagnosis_and_management._NICE_guideline__NG115__142.jpg)
[C] Chronic obstructive pulmonary disease in over 16s diagnosis and management. NICE guideline [NG115].pdf
![[Fii] Acpin trial offer.pdf](/uploads/r/null/2/b/5/2b530c9146e62af26d520e9afc12665049d8575e7ed7bda7708b2bafa4838f59/726531e9-2d6e-4878-bae9-a5a9e468dc60-_Fii__Acpin_trial_offer_142.jpg)
[Fii] Acpin trial offer.pdf
![[Hii] Key Opinion Leaders and Rehabilitation Centres.pdf](/uploads/r/null/4/f/1/4f1c52d510d5675024c6fb049e5a8d7cbe007e2b4d63908a10830ce5f672e5b3/27642ce1-b683-4da2-af04-37086401c8ba-_Hii__Key_Opinion_Leaders_and_Rehabilitation_Centres_142.jpg)
[Hii] Key Opinion Leaders and Rehabilitation Centres.pdf
![[D] Rehabilitation at home.pdf](/uploads/r/null/f/4/d/f4d731fe29fcf743a83011c313df46671ae3a95f9ef76cf442fe7863892231b3/4d9c518c-f9ce-4a49-a695-1c2e1331d7e3-_D__Rehabilitation_at_home_142.jpg)
[D] Rehabilitation at home.pdf
![[E] Gripable.pdf](/uploads/r/null/e/0/f/e0f64843ce268f456826f2649f1e7a53fd8aa410733049cbb01e40764bbf7dd1/3860ccf0-46fb-4b5c-8b13-74614a09e3e2-_E__Gripable_142.jpg)
[E] Gripable.pdf